#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer Cutaneous calcification Round cell liposarcoma Peripheral primitive neuroectodermal tumour of soft tissue Metastases to central nervous system Transient ischaemic attack Sexually transmitted disease Small intestine neuroendocrine tumour Piriformis syndrome Myeloproliferative neoplasm Congenital aplastic anaemia Hyperphagia Herpes simplex Fragile X syndrome Pulmonary sarcoidosis More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Congenital nephrogenic diabetes insipidus – Diagnostics Progressive supranuclear palsy – Trials in Disease Pemphigus – Trials in Disease Lymphatic malformation – Basic Information Gastrointestinal stromal tumour – Treatment Primary mediastinal large B-cell lymphoma – Trials in Disease Chondrosarcoma – Diagnostics Systemic sclerosis pulmonary – Basic Information Choroid melanoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etripamil Hydrocortisone Hemisuccinate Amiodarone Hydrochloride Obefazimod Msv/As Jab-21822 Doxylamine Hydrogen Succinate HSP-CAR19M Rituximab Sphingomyelin (Egg) Tominersen Human Apotransferrin Cart45Ra-Nkg2D Cells Tetracycline Hydrochloride Metamizole Magnesium Inclisiran Sodium Gadobenate Dimeglumine Nalbuphine Hydrochloride Salbutamol Bendamustine More therapies…

    Learn about Your Condition

    Lipid metabolism disorder Pleural mesothelioma malignant Supranuclear palsy Arrhythmia supraventricular Amyloidosis Cardiac failure congestive Medullary thyroid cancer Infertility male Oxygen saturation Osteosarcoma recurrent Muscular dystrophy Heart transplant Pancoast's tumour Uveitis Hypoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Bacs-Kiskun Varmegyei Oktatokorhaz

Bacs-Kiskun Varmegyei Oktatokorhaz

Nyiri Ut 38, Kecskemet, 6000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Czechia Estonia France Germany Hungary Italy +6

  • Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Dextran 70
    • Tisotumab Vedotin
    • Hypromellose
    Austria Belgium Czechia Finland France Germany +7

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Belgium Bulgaria Estonia France Greece Hungary +5

  • Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • SIGVOTATUG VEDOTIN
    • Docetaxel
    Austria Belgium Czechia France Germany Greece +7

  • Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lanreotide
    • Octreotide
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute cardiac event
    • Acute myocardial infarction
    • Myocardial ischaemia
    Investigated Drugs:
    • Zalunfiban
    Czechia France Hungary The Netherlands Romania

  • Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin
    • Abemaciclib
    • Giredestrant
    Austria Belgium Finland France Germany Greece +7

  • Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Enzalutamide
    • Pembrolizumab
    Austria Bulgaria Czechia France Germany Hungary +5

  • Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pembrolizumab
    Austria France Germany Hungary Italy The Netherlands +4

  • Study of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems

    Not recruiting

    2 1
    Investigated Diseases:
    • Lipoprotein metabolism disorder
    Investigated Drugs:
    • Ly3473329
    Germany Hungary The Netherlands
Previous Page
1 … 9 10 11 12 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!